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Abstract: Coronavirus disease 2019 (COVID-19) has shown the importance of postmortem investiga-
tion of deceased patients. For a correct interpretation of the pulmonary findings in this new era, it
is, however, crucial to be familiar with pathologic pulmonary conditions observed in postmortem
investigations in general. Adequate postmortem histopathological evaluation of the lungs may be
affected by suboptimal gross work up, autolysis or poor fixation. Using a standardized preparation
approach which consisted in instillation of 4% buffered formaldehyde through the large bronchi
for proper fixation and preparing large frontal tissue sections of 1–2 cm thickness after at least 24 h
fixation, we comprehensively analyzed postmortem pulmonary findings from consecutive adult
autopsies of a two-year period before the occurrence of COVID-19 (2016–2017). In total, significant
pathological findings were observed in 97/189 patients (51%), with 28 patients showing more than
one pathologic condition. Acute pneumonia was diagnosed 33/128 times (26%), embolism 24 times
(19%), primary pulmonary neoplasms 18 times (14%), organizing pneumonia and other fibrosing
conditions 14 times (11%), pulmonary metastases 13 times (10%), diffuse alveolar damage 12 times
(9%), severe emphysema 9 times (7%) and other pathologies, e.g., amyloidosis 5/128 times (4%).
Pulmonary/cardiopulmonary disease was the cause of death in 60 patients (32%). Clinical and patho-
logical diagnoses regarding lung findings correlated completely in 75 patients (40%). Autopsy led to
confirmation of a clinically suspected pulmonary diagnosis in 57 patients (39%) and clarification of
an unclear clinical lung finding in 16 patients (8%). Major discrepant findings regarding the lungs
(N = 31.16%) comprised cases with clinical suspicions that could not be confirmed or new findings
not diagnosed intra vitam. A significant proportion of acute pneumonias (N = 8; 24% of all cases
with this diagnosis; p = 0.011) was not diagnosed clinically. We confirmed the frequent occurrence
of pulmonary pathologies in autopsies, including inflammatory and neoplastic lesions as the most
frequent pathological findings. Acute pneumonia was an important cause for discrepancy between
clinical and postmortem diagnostics
Keywords: pulmonary pathology; postmortem diagnostics; autopsy
1. Introduction
The recent advent of Coronavirus disease 2019 (COVID-19) has turned the focus on pul-
monary findings of deceased patients. Postmortem investigations of the lungs of COVID-19
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patients have contributed significantly to the understanding of this disease [1–4]. Apart
from this recent development, pathological pulmonary findings in adults are frequently
encountered at postmortem examinations, either as the leading cause of death [5–13] or as
a secondary significant finding, however unrelated to the cause of death. They comprise
inflammatory or immunologic conditions, primary or secondary tumors, fibrotic changes
or degenerative, often emphysematous conditions. Inflammatory and fibrotic changes may
be challenging to categorize clinically, and autopsies may confirm or contradict a proposed
clinical diagnosis. Moreover, discrepancy between clinical and postmortem pathologic
findings is well-known [6–13].
Despite a large amount of literature on pulmonary findings in postmortem diagnostics,
including a vast number of case reports (>5100 hits for PubMed search: “case report” and
“pulmonary pathology” and “autopsy” [14]) and epidemiologically oriented studies exam-
ining the cause of death [5], data focusing particularly on pulmonary findings obtained
from larger autopsy series—apart from recent COVID-19 publications—are surprisingly
scarce. Knowledge about autoptic pulmonary pathology in general, however, is a crucial
prerequisite for a reliable diagnostic process, in particular when faced with the task of
describing a novel disease as the world has experienced it dramatically in 2020.
Postmortem analysis of the lungs may be affected by several pre-analytical factors
including suboptimal gross work up, autolysis or poor fixation, which particularly impedes
proper histopathological evaluation. Our postmortem lung work-up was revised and
standardized within the context of restructuring the autopsy department of the Institute of
Pathology of the University of Bern to a “Postmortem Diagnostic (PMD) Unit” as described
in detail elsewhere [15], consisting in instillation of formaldehyde through the large bronchi
and preparing large frontal tissue sections after proper fixation.
In order to gain a more comprehensive overview of postmortem pulmonary pathology
findings, we prospectively collected all data on lung pathology findings obtained from
consecutive adult autopsies during a period of two years using this standardized approach
and compared them with clinical diagnoses.
2. Materials and Methods
2.1. Postmortem Diagnostic Procedure
Both lungs were removed after evisceration of the heart and evaluation of the large
pulmonary arteries for central pulmonary emboli. Four percent buffered formaldehyde
was instilled through the large bronchi using a large 60 mL syringe [16]. After fixation for
at least 24 h, large frontal tissue sections of 1–2 cm thickness were prepared using a support
device tailor-made for the purpose of lung sectioning. This approach allows complete
expansion of the parenchyma and prevents artifacts due to dystelectases or poor fixation. In
contrast to the original description [16], we decided to perform fixation for a longer period
than one hour. After sectioning, the parenchyma was carefully evaluated. Standardized
histology samples were taken from every lobe and from macroscopically abnormal areas, if
identified. Histological stains comprised hematoxylin-eosin for all samples and additional
Periodic acid-Schiff (PAS) reaction, Elastica van Gieson (EvG) and Iron stain on at least
one tissue block. Grocott’s methenamine silver (GMS) staining was only performed in
cases with suspicion of fungal infection if PAS staining was negative (Figure 1 shows
representative macroscopic and histologic images of selected cases).
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Figure 1. Illustrative examples of postmortem findings in the lungs: (A–E) Case 1: Clinical Diagno-
sis: pulmonary bleeding, most probably due to a central lung cancer. (A) Large transversal section 
shows a large bronchial carcinoma, centrally located with infiltration and with arrosion of large 
vessels and bronchi (A,B). Additionally, in the lower lobe, a second tumor was identified (A,C). 
Histologically, the central tumor was a poorly differentiated squamous cell carcinoma (D). The tu-
mor in the lower lobe (E) was a well differentiated squamous cell carcinoma, due to the different 
morphology considered to be a second, independent malignancy. (F–H) Case 2: Clinical Diagnosis: 
diffuse metastasizing melanoma. F: multiple, partially inhomogeneous (*), partially well circum-
scribed (#) nodules and indurations in the lungs. Histological coexistence of acute bronchopneumo-
nia (G, corresponding to *) and multiple intravascular infiltrations of melanoma (H, corresponding 
to #). No parenchymatous metastases were detected. I–L Case 3: Clinical Diagnosis: unclear pulmo-
nary fibrosis. I: Patchy consolidations in all lobes. (K) Corresponding CT scan. Histology showed 
organizing pneumonia (L). All histological stains are Hematoxylin/ and Eosin; original magnifica-
tion 20×. 
Figure 1. Illustrative examples of postmortem findings in the lungs: (A–E) Case 1: Clinical Diagnosis:
pulmon ry bleedi g, most probably due to a central lung cancer. (A) Large transversal section shows
a large bronchial carcinoma, centrally located with infiltration a with arro ion of large vessels and
bronchi (A,B). Additionally, in the lower lobe, a second tumor was identified (A,C). Histologically, the
central tumor was a poorly differentiated squamous cell carcinoma (D). The tumor in the lower lobe
(E) was a well differentiated squamous cell carcinoma, due to the different morphology considered
to be a secon , indepen ent malignancy. (F– ) Case 2: Clin cal Diagnosis: diffuse metastasizing
melanoma. F: multiple, p rtially inhomogeneous (*), partially well circumscribed (#) odules and
indurations in the lungs. Histological coexistence of acute bronchopneumonia (G, corresponding to *)
and multiple intravascular infiltrations of melanoma (H, corresponding to #). No parenchymatous
metastases were detected. (I–L) Case 3: Clinical Diagnosis: unclear pulmonary fibrosis. (I): Patchy
consolidations in all lobes. (K) Corresponding CT scan. Histology showed organizing pneumonia
(L). All histological stains are Hematoxylin/ and Eosin; original magnification 20×.
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2.2. Patients
During the period of two years after the introduction of the new technique in January
2016, data from all adult autopsy cases (patients 18 years and older; N = 189; 2016–2017)
were prospectively collected. The findings were retrospectively correlated with clinical
questions regarding pulmonary pathology and discrepancies between pathology and
clinical findings were recorded. The study was performed in accordance with the Swiss
Research Act as confirmed by the Ethics commission of the Canton Bern (2017-01189).
2.3. Data Recording
Demographic analysis, gender and age of the deceased patients were recorded, as
well as the requesting hospital and department (Intensive Care Unit of the University
Hospital, other departments of the University Hospital, peripheral hospitals and privately
commissioned autopsies). In line with literature [17,18], the cause of death was categorized
into sepsis/peritonitis, cardiopulmonary failure, cerebrovascular lesion, pulmonary em-
bolism, pneumonia, myocardial infarction, gastrointestinal hemorrhage, hepatic failure,
intestinal ischemia, malignancy, aortic rupture/cardiac tamponade and other. Pulmonary
findings were classified into normal, congestion, mild emphysema, diffuse alveolar dam-
age (DAD), acute pneumonia, organizing pneumonia, primary pulmonary neoplasm,
pulmonary metastases, central pulmonary embolism, paracentral and peripheral embolism,
fibrosis other than organizing pneumonia, severe emphysema (defined as Grade 4 and
more according to Nagai et al. [19]) or other pathology. This categorization was used both
for the predominant lung findings and for additional pulmonary pathologies if present.
Heart weight and lung weight prior to fixation were recorded. Clinical questions listed
in the request documents regarding pulmonary findings were categorized as follows: no
question, primary tumor, secondary tumor (metastasis), inflammation, degeneration in-
cluding emphysema, fibrosis. The correlation with clinical questions regarding the lungs
was defined as consistent, specific clinical question clarified by postmortem examination
(e.g., clinically suspected pulmonary embolism), unspecific or vague clinical question an-
swered or clarified by postmortem examination (e.g., unclear opacity), clinical suspicion of
specific finding but discrepant finding in postmortem examination, finding in postmortem
examination not suspected clinically.
2.4. Statistics
The IBM SPSS software V26 (SPSS Inc., Chicago, IL, USA) was used for statistical
analysis. Descriptive analyses were performed using simple cross tables. Comparison
between groups was performed using Chi-square tests and Fisher’s exact tests and Median
tests. p-values of <0.05 were considered statistically significant.
3. Results
3.1. Patient Characteristics and Causes of Death
Postmortem procedures were conducted on 189 consecutive adult patients. A total of
63 (33%) were women and 126 (66%) men. The median age was 69 years (range: 26–104). All
postmortem examinations consisted of diagnostic autopsies, excluding minimally invasive
approaches where the described method of lung preparation was technically not feasible.
Thirty-two (17%) autopsies were from the intensive care unit and 34 (18%) from other
departments of the University Hospital Bern (Inselspital). Most autopsies (119; 63%) were
solicited by community hospitals, and four (2%) autopsies were commissioned by others
(general practitioners, relatives). The most frequent cause of death was cardio-pulmonary
failure (N = 54; 29%), including 18 cases (10%) with a predominant respiratory component
(DAD, N = 7; severe emphysema, N = 7; fibrosis, N = 4), followed by malignant neoplasm
(N = 27; 14%), including 12 cases with primary lung cancer (3%), myocardial infarction
(N = 21; 11%), pneumonia (N = 20; 11%), sepsis or peritonitis (N = 12; 6%), aortic rupture
(N = 11; 6%), gastrointestinal hemorrhage (N = 11; 6%) and pulmonary embolism (N = 10;
5%). Less frequent causes of death were cerebral and cerebrovascular conditions (N = 7;
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4%), hepatic failure (N = 6; 3%), intestinal ischemia (N = 2; 1%) and others (N = 8; 4%).
In summary, pulmonary pathologies predominantly contributed to 60/189 deaths (32%)
(Table 1).
Table 1. Cause of death in consecutive adult autopsies from a 2-year period (2016–2017).
Cause of Death N %
Cardiopulmonal failure 54 29
(predominant respiratory component) (18) (10)
Myocardial infarction 21 11
Neoplasm 27 14
Pneumonia 20 11
Sepsis or peritonitis 12 6
Gastrointestinal hemorrhage 11 6
Aortic rupture 11 6
Pulmonary embolism 10 5
Cerebral/cerebrovascular 7 4
Hepatic failure 6 3
Intestinal ischemia 2 1
Others 8 4
Total 189 100
Lung specific clinical questions had been asked in the autopsy request forms in
104 cases (55%), in particular with regard to neoplasms (N = 32; 17%), pneumonia (N = 19;
10%), emphysema (N = 24; 13%) and idiopathic pulmonary fibrosis (N = 1). In 28 cases
(15%), the clinical findings in the lungs were stated as unclear.
3.2. Pathological Pulmonary Findings
The lungs were normal in 7/189 patients (4%). Sole congestion due to cardiac failure
was diagnosed in 51 patients (27%) and mild emphysema in 34 patients (16%). Among
those, 26 patients had both mild emphysema and congestion. These findings, however,
were considered minor or non-significant primary pulmonary pathologies and were not
included into further analyses. Thus, 97/189 patients (51%) presented with significant
pulmonary pathology at postmortem work-up. A total of 28/189 (15%) patients had addi-
tional significant pulmonary pathology diagnoses (again, excluding congestion (N = 12)
and mild emphysema (N = 51) as secondary pulmonary findings). In summary, in total,
128 significant pathologic diagnoses were finally found in 189 patients with the following
frequencies: acute pneumonia was diagnosed 33/128 times (26%), embolism 24 times (19%),
primary pulmonary neoplasms 18 times (14%), organizing pneumonia and other fibrosing
conditions 14 times (11%), pulmonary metastases 13 times (10%), diffuse alveolar damage
12 times (9%), severe emphysema 9 times (7%) and other pathologies, e.g., amyloidosis
5/128 times (4%) (Figure 2).
With regard only to the predominant pulmonary pathological findings, there was
acute pneumonia in 29 patients (15%), primary pulmonary neoplasms in 17 patients (9%),
DAD in 12 patients (6%), metastases in 9 patients (5%), central embolism in 7 patients
(4%), significant emphysema in 7 patients (4%), organizing pneumonia and other fibrosing
conditions in 7 patients (4%), paracentral and peripheral emboli in 6 patients (3%) and
other pathologies in 3 patients (2%).
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Figure 2. Overview of pulmonary pathologies found in consecutive adult autopsies from a 2-year period (2016–2017). A 
total of 197/189 patients showed significant pulmonary pathologies at postmortem examination (left side). A total of 28 patients 
had more than one pulmonary pathologic finding, leaving a total of 128 significant pulmonary diagnoses (right side). 
3.3. Correlation with Demographic Data and Clinical Findings 
There was no significant correlation between the presence or type of pulmonary pa-
thology and patients’ gender (p = 0.87) or age (p = 0.44). DAD was the only predominant 
pulmonary diagnosis that was rendered more frequently in patients from the intensive 
care unit of the university hospital (7/12; 58%; p = 0.023). The highest lung weights were 
observed in DAD with a median weight of 1570 g (95% CI 1340 g–2090 g), in contrast to 
normal lungs with a median weight of 792 g (95% CI 560 g–1330 g). 
Acute pneumonias (N = 20), pulmonary embolism (N = 10) and DAD and severe em-
physema leading to cardiopulmonary failure (N = 7 each) were the most frequent causes 
of death associated with pulmonary pathologies and were observed in 60/189 deaths 
(32%). Acute pneumonias, however, were also diagnosed as additional findings in pa-
tients who died due to cerebral or cerebrovascular conditions (N = 2/7) or due to hepatic 
failure (N = 3/3). In contrast, in patients who died due to aortic ruptures or myocardial 
infarction, significant pulmonary pathologies—excluding congestion and mild emphy-
sema—were only rarely seen (N = 1/12 for aortic rupture and N = 5/20 for myocardial 
infarction with 3 co-existing lung neoplasms), which was an expected finding. 
3.4. Comparison between Clinical Diagnoses and Postmortem Findings 
Comparisons of postmortem pulmonary findings with clinical diagnoses and ques-
tions revealed complete agreement in 75/189 cases (39.7%), clinical suspicion for a specific 
finding confirmed by postmortem examination in 57/189 cases (29.6%), unclear clinical 
finding and a specific finding at postmortem examination in 16/189 cases (9%), a suspicion 
for a specific finding not confirmed at postmortem examination in 9/189 cases (5.3%) and 
a specific finding at autopsy in the absence of clinical suspicion in 32 cases (16.9%). In 
summary, major discrepant findings regarding pulmonary pathology (i.e., the latter two 
categories) were found in 41/189 cases (21.7%). There was no difference between discrep-
ancies and concordant or confirming diagnoses regarding patients’ age, gender, hospital 
or department (p > 0.2 each). The most common diagnosis with discrepancies was acute 
Figure 2. vervie of pul onary pathologies found in consecutive adult autopsies from a 2-year period (2016–2017).
A total of 197/189 patients showed significant pulmonary pathologies at postmortem examination (left side). A total
of 28 patients had more than one pulmonary pathologic finding, leaving a total of 128 significant pulmonary diagnoses
(right side).
3.3. Correlation with Demographic Dat and Clinical Findings
There was no significant correlation between the presence or type of pulmonary
pathology and patients’ gender (p = 0.87) or age (p = 0.44). DAD was the only predominant
pulmonary diagnosis that was rendered more frequently in patients from the intensive
care unit of the university hospital (7/12; 58%; p = 0.023). The highest lung weights were
observed in DAD with a median weight of 1570 g (95% CI 1340 –2090 g), in contrast to
normal lungs with a median weight of 792 g (95% CI 560 g–1330 g).
Acute pneum nias (N = 20), pulmonary embolism (N = 10) and DAD and severe
emphysema leading to cardiopulmonary failure (N = 7 each) were the most frequent cause
of death associated with pulmonary pathologies nd were observed in 60/189 deaths
(32%). Acute pneumonias, however, w re also diagnose as additional findings in patients
who died due to cerebral or cerebrovascular conditions (N = 2/7) or due to hepatic f ilure
(N = 3/3). In contr st, in patients who died due to aortic ruptures or myocardial infarction,
ignificant pulmon y pathologies—excluding conges ion mild emphysema—were
only rarely seen (N = 1/12 for aortic rupture and N = 5/20 for myocard al farction with
3 co-existing lung neoplasms), which was an expected finding.
3.4. Comparison between Clinical Diagnoses and Postmortem Findings
Comparisons of postmortem pulmonary findings with clinical diagnoses and ques-
tions revealed complete agreement in 75/189 cases (39.7%), clinical suspicion for a specific
finding confirmed by postmortem examination in 57/189 cases (29.6%), unclear clinical
finding and a specific finding at postmortem examination in 16/189 cases (9%), a suspicion
for a specific finding not confirmed at postmortem examination in 9/189 cases (5.3%) and
a specific finding at autopsy in the absence of clinical suspicion in 32 cases (16.9%). In
summary, major discrepant findings regarding pulmonary pathology (i.e., the latter two
categories) were found in 41/189 cases (21.7%). There was no difference between discrep-
ancies and concordant or confirming diagnoses regarding patients’ age, gender, hospital
or department (p > 0.2 each). The most common diagnosis with discrepancies was acute
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pneumonia (N = 10/29 cases discrepant), followed by metastases (N = 5/9) and paracen-
tral/peripheral emboli (N = 4/6) when analyzing the predominant pulmonary pathologies.
In contrast, primary pulmonary malignancies were almost always known (N = 16/17), as
well as severe emphysema (N = 6/7) and central pulmonary emboli (N = 5/7) and organiz-
ing pneumonia or fibrosis (N = 6/7). Overall, this correlation was significant (p = 0.012)
(Table 2). For the additional pulmonary pathologies, no association with the categories of
discrepancies was found (p = 0.44).
















acute pneumonia 16 3 10
metastases 4 0 5
paracentral and peripheral embolism 2 0 4
primary pulmonary neoplasm 15 1 1
congestion 42 3 6
normal 7 0 0
organizing pneumonia 2 0 1
DAD 9 1 2
severe emphysema 3 3 1
central embolism 5 0 2
mild emphysema 21 5 8
fibrosis 4 0 0
other 2 0 1
total 132 16 41
4. Discussion
We present a comprehensive single center study on postmortem pulmonary pathology
findings in 189 adults obtained during a two-year period from 2016–2017. We used a
standardized method for gross preparation and histological work up of the lungs consisting
in instillation of formaldehyde through the large bronchi and preparing large frontal tissue
sections after proper fixation [15].
Half of the patients had one or more significant pulmonary pathology finding at
postmortem examination, with pulmonary disease as cause of death in one third of the
cases. Leaving out mild emphysema and congestion due to cardiac failure, the most
frequent diagnoses were acute pneumonia, embolism, tumors and diffuse alveolar damage
(DAD) followed by fibrosing conditions and severe emphysema. In most cases, there
was a correlation between clinical and pathological diagnoses, including the confirmation
of clinically suspected findings. In a low number of cases an unclear clinical finding
was clarified. However, in a considerable number of patients, there were true discrepant
findings regarding the lungs.
In the literature before the COVID-19 era, there are only few studies that compre-
hensively report postmortem pulmonary pathology data. In a smaller study from India,
including 86 cases, the prevalence of lung pathology findings in autopsies was 65%. This
is higher compared to our study, but the authors included congestion and edema caused
by cardiac failure in their list of diagnoses [20]. Apart from that, the range of pathologies
comprised mainly inflammatory diseases. In contrast to our study, surprisingly, there
were no neoplasms reported. This may be explained by the very different cultural and
environmental background or a referral bias. In a longitudinal epidemiologic study from
Norway, the prevalence of pulmonary diseases was examined in the general population
including data from autopsies, with neoplasms and pneumonia being reported as the most
frequent pulmonary diseases contributing to the death of the patients [5].
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In contrast, many original publications concentrate on one particular pulmonary
disease complex: in one series, for example, pulmonary embolism as cause of death
was studied in detail [21]. In our study, pulmonary embolism was observed in around
one quarter of cases, in half of these cases contributing significantly to the death of the
patients. Other studies describe histomorphological findings of patients with idiopathic
pulmonary fibrosis (IPF) and observe that in the majority of patients exacerbation rather
than progression leads to the fatal outcome of the disease [22,23]. In our study, the specific
clinical question for IPF was asked in one case only, but there were additional cases
with other fibrotic lesions, such as organizing pneumonia or severe emphysema with
associated fibrosis.
Acute pneumonias, including four cases with fungal infections, were the most fre-
quent significant pulmonary pathologies observed in this study. They were a frequent
cause of death but also occurred as additional findings, e.g., in patients who died due to
terminal liver failure. In these cases, however, pneumonias could well represent the un-
derlying reason for the development of final hepatic failure in patients with liver cirrhosis.
Pneumonias contributed also to the cases with discrepancies between clinical diagnosis
and autopsy finding (both newly detected and non-confirmed). Comparable results on
inflammatory diseases have been observed in a study on patients in intensive care units,
however, without focusing on lung findings [13].
DAD was more frequently diagnosed compared to other case series, e.g., in a forensic
setting [24]. DAD can not only occur as a primary disease manifestation but also as a side
effect of ventilation [25] or extracorporeal membranous oxygenation, which explains the
expected high rate in patients from the intensive care unit [26]. Moreover, it can occur in
association with infections, most frequently viral (including, but not limited to COVID-
19 [1,3,27,28]) and caused by fungi, e.g., pneumocystis jiroveci. In our case collection,
DAD was observed in association with lung fibrosis, tumors, including postoperative
complications and most frequently with acute pneumonia.
Studies focusing on malignancies report only few incidentally detected lung can-
cers [27]. Concordantly, primary lung neoplasms were not a frequent reason for diagnostic
error in our study. If this occurred, it was due to rare malignancies with a challenging
diagnostic course such as intravascular large B-cell lymphoma [28]. Interestingly, the
primary cause of death in lung cancer patients was primarily attributable to general tumor
burden, followed by secondary infections and complications of metastases [29]. In our
series, we also observed cardiovascular diseases and other pulmonary pathologies as a
cause of death in patients with lung malignancies.
An example of a rare pulmonary pathology finding is pulmonary amyloidosis, which
was detected in 76 patients during a period of 20 years in a study from the USA [30]. In
our series, we identified four cases with pulmonary amyloidosis.
In view of the current global situation, it should be emphasized that many of the
pathologies observed in this study may contribute to a severe course of a COVID-19 infec-
tion, including also mild emphysema that we would have interpreted as “non-significant”
pathology during the prospective collection of the cases of our study.
Many publications on autopsies focus on discrepancies between clinical and patholog-
ical diagnoses, most of them applying the Goldman Criteria [31] for the categorization of
diagnostic errors. In studies of patients from intensive care units up to 20% major errors
have been reported [32]. Similar rates for major diagnostic errors were also observed in a
very recent, large meta-analysis [12]. We did not apply the original Goldman criteria, since
they refer to the synopsis of all postmortem findings in correlation to clinical diagnoses,
but used a modified system to categorize the correlations and discrepancies between pre-
and postmortem findings.
Discrepancies and diagnostic errors are still rather prevalent although they are de-
clining due to better diagnostic tools [11,12,33,34]. Pulmonary diseases, particularly pneu-
monia and pulmonary embolism, are amongst the most prevalent causes of diagnostic
discrepancies between clinical and autopsy diagnoses—less frequent than cardiovascular
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events but more frequent than malignancies [6–9,12,13,18,35,36]. Consistent with that, we
also observed that in 5% of the cases pulmonary pathologies contributed to true discrep-
ancies. The value of postmortem examinations, however, is not limited to detecting the
cause of death or demonstrating diagnostic errors, but encompasses clarification of unclear
clinical findings and confirmation of suspected or clinically clear diagnoses. In fact, many
pathological findings that we detected did not directly contribute to the fatal outcome nor
were they the source of discrepancies between clinical and autopsy diagnosis, including
some cases with pneumonia, emphysema, malignancies, and fibrosing lesions.
From a technical point, we think that the technique we applied allows precise macro-
scopic and histopathological evaluation of the lungs, with a good preservation of histology
due to proper fixation and only minor artifacts caused by mechanical compression due to
the good expansion of the organs. This may be of particular importance for the postmortem
assessment of fibrosing diseases and of DAD. Similar to fibrosing lesions and with an
overlap in organizing DAD, the evaluation of instilled and expanded airway spaces may
increase the diagnostic accuracy for delicate findings such as minor hyaline membranes or
may allow exact localization of fibrotic changes in the different anatomic compartments
of the lung parenchyma. Since both macroscopy and histology can be performed with-
out facing major artefacts, thus enhancing diagnostic certainty of pathological diagnoses,
this approach is now considered method of choice for postmortem lung diagnostics in
the institute.
There are several limitations of this study, including the presented technique. Clinical
information was obtained mostly from the autopsy request forms. At this time, complete
patient’s records were not routinely available before the conduction of the autopsies. While
the macroscopic findings of many cases were discussed with the clinicians, only a minority
of the cases were discussed in clinico-pathological conferences or multidisciplinary boards
where radiologists attended the discussion. Non-availability of data, however, may con-
tribute to diagnostic discrepancies on a systematic level [33]. Electronic patient records that
are available to the pathologist may therefore also contribute to a further decline of discrep-
ancy rates besides improved intravital diagnostics [10]. Next, the method of the preparation
is labor intensive and may require a complex organization of the autopsy service. For the
investigation of the complete lungs, it is necessary to keep the entire organs, which may
potentially interfere with legal regulations. In Switzerland, larger tissue samples may be
kept for further processing, if deemed necessary for adequate diagnosis, at the discretion
of the attending staff pathologist. This may not be possible in certain countries, such
as, e.g., the United Kingdom. In other countries, preserving complete organs for careful
histological analysis later on may also be within a legal grey zone. Formalin instillation has
to be performed exclusively through the bronchi since embolic material may be flushed
further proximally by the instillation of liquid. Undirected sampling for microbiology can
be performed from the outside before formalin installation, but targeted sampling is not
possible. In particular cases, modification of this method or using alternative preparation
approaches may be indicated, e.g., in cases where complete dissection along the pulmonary
arteries and bronchi would be more useful. In view of our results and personal experience,
however, we suggest that the presented preparation technique should be considered as
first choice, in general or at least in the context of particular clinical questions regarding
the lungs such as fibrosing diseases or acute respiratory distress syndrome corresponding
to the pathologic diagnosis of DAD.
5. Conclusions
Taken together, this descriptive explorative study highlights the high frequency and
variety of pulmonary pathologic findings obtained from postmortem investigations ap-
plying a standardized preparation technique for postmortem diagnostics of the lungs that
allows excellent macroscopical and histopathological evaluation. Moreover, we could
demonstrate that acute pneumonia is still a considerable cause for discrepancy between
clinical and postmortem diagnostics. Correlation analysis, however, should not only fo-
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cus on discrepancies, which are consistently reported in a certain number of cases. The
comparison between clinical and autopsy diagnoses should also value confirmatory re-
sults in clinically ambiguous cases. A positive feedback loop in case of consistent clinical
and autopsy diagnoses should not be underestimated in view of continuous medical ed-
ucation [33,34,37–39]. The recent example of COVID-19 has shown both the impact of
postmortem diagnosis for the understanding of this novel disease [40–43] but has also
highlighted the need of profound knowledge about general pathologic conditions, in par-
ticular, of the lungs in order to accurately interpret the findings and to separate newly
discovered characteristics from well-known unspecific features. In this work, we have
presented postmortem pulmonary pathology as an example of a particular organ specific
aspect of autopsy or postmortem diagnostics, respectively, and we could demonstrate that
this sub-discipline of pathology still fulfills the duty of quality assurance and education of
medical professionals including clinicians, radiologists and pathologists.
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